Results 311 to 320 of about 1,193,518 (407)

Antimicrobial Resistant <i>Staphylococcus</i> spp., <i>Escherichia coli</i>, and <i>Salmonella</i> spp. in Food Handlers: A Global Review of Persistence, Transmission, and Mitigation Challenges. [PDF]

Pathogens
Viana GGF, Cardozo MV, Pereira JG, Rossi GAM.   +3 more
europepmc   +1 more source

Frequency of Penicillin-resistant Staphylococcus [PDF]

, 1949
A. Voureka, W. H. Hughes
openalex   +1 more source

Extract from <i>Rosa</i> spp. as a Factor Influencing the Growth Rate of Coagulase-Negative <i>Staphylococcus</i> Strains. [PDF]

Molecules
Piekarska-Radzik L, Milala J, Klewicki R, Sójka M, Żyżelewicz D, Matysiak B, Klewicka E.   +6 more
europepmc   +1 more source

Elexacaftor–Tezacaftor–Ivacaftor Improves Sinonasal Outcomes in Young Children With Cystic Fibrosis

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Severe chronic rhinosinusitis (CRS) is a near universal manifestation of cystic fibrosis. Elexacaftor/tezacaftor/ivacaftor (ETI) is an oral, small molecule, highly effective Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) corrector–potentiator drug.
Amanda L. Stapleton, Adam Kimple, Jennifer L. Goralski, Daniel M. Beswick, Anshika Gupta, Douglas A. Li, Barton F. Branstetter, S. Mehdi Nouraie, Amber D. Shaffer, Brent Senior, Anna C. Zemke   +10 more
wiley   +1 more source

Correction: Antimicrobial resistance profile of Staphylococcus aureus isolated from patients, healthcare workers, and the environment in a tertiary hospital in Addis Ababa, Ethiopia. [PDF]

PLoS One
Ibrahim RA, Wang SH, Gebreyes WA, Mediavilla JR, Hundie GB, Mekuria Z, Ambachew R, Teklu DS, Kreiswirth B, Seyoum ET, Beyene D, Berhe N.   +11 more
europepmc   +1 more source

Beyond the Lung. Impact of Elexacaftor/Tezacaftor/Ivacaftor on Sinonasal Disease in Children With Cystic Fibrosis

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Elexacaftor/tezacaftor/ivacaftor (ETI) is a Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) therapy that improves pulmonary function and chronic rhinosinusitis (CRS) in cystic fibrosis (CF) adults with at least one copy of the F508del CFTR mutation.
Margaux Petitjean, Alexia Letierce, Anne‐Sophie Bonnel, Philippe Reix, Eric Deneuville, Nathalie Stremler, Romain Luscan, Vincent Couloigner, Laurent Mely, Katia Bessaci, Guillaume Labbe, Christophe Marguet, Mairead Kelly‐Aubert, Fatiha Hassani, Isabelle Sermet‐Gaudelus, François Simon, the MODUL‐CF Study Group   +16 more
wiley   +1 more source

Saarvienin A—A Novel Glycopeptide with Potent Activity against Drug‐Resistant Bacteria

Angewandte Chemie, EarlyView.
A structurally distinct glycopeptide, saarvienin A, represents a new family of glycopeptide antibiotics consisting of five sugar/aminosugar units connected to a halogenated peptide core. Saarvienin A overcomes vancomycin resistance and shows strong activity against drug‐resistant Gram‐positive bacteria, in particular, high‐priority pathogens such as ...
Amninder Kaur, Jaime Felipe Guerrero‐Garzón, Sari Rasheed, Martin Zehl, Franziska Fries, Bernd Morgenstern, Sergey B. Zotchev, Rolf Müller   +7 more
wiley   +2 more sources

Isolation and assessment of antibiotic resistance of Staphylococcus aureus in the air of an underground hard coal mines. [PDF]

Sci Rep
Paśmionka IB, Cheluszka P, Gospodarek J, Chmielowski K, Fries J.   +4 more
europepmc   +1 more source

Discovery and Biosynthesis of Celluxanthenes, Antibacterial Arylpolyene Alkaloids From Diverse Cellulose‐Degrading Anaerobic Bacteria

Angewandte Chemie, EarlyView.
The structure and biosynthetic origin of the enigmatic “yellow affinity substance” (YAS) from the anaerobe thermophile Clostridium thermocellum (now: Acetivibrio thermocellus) were elucidated. YAS is a complex of unusual antibacterial arylpolyene alkaloids (celluxanthenes) that are produced by various cellulolytic anaerobes.
Keishi Ishida, Jana Krabbe, Philippe R. Meisinger, Gulimila Shabuer, Sebastian Schieferdecker, Michael Cyrulies, Cedric Tank, Emma Barnes, Christian Paetz, Christian Hertweck   +9 more
wiley   +2 more sources

The burden of antimicrobial resistance in biofilm forming <i>Staphylococcus</i> spp. from Vernal Keratoconjunctivitis patients eyes. [PDF]

Biofilm
Rupa N, Donthineni PR, Basu S, Arunasri K.   +3 more
europepmc   +1 more source